Tucson, AZ, United States of America

Crystal Schemp

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Crystal Schemp: Innovator in Cancer Treatment Technologies

Introduction

Crystal Schemp is a notable inventor based in Tucson, AZ (US), recognized for her contributions to cancer treatment technologies. With a total of 4 patents, she has made significant strides in the field of oncology, particularly in identifying treatment-responsive non-small cell lung cancer (NSCLC) and improving breast cancer prognosis.

Latest Patents

One of her latest patents is a method for identifying treatment-responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker. This innovative method involves identifying a sample containing NSCLC tumor cells as either ALK-positive or ALK-negative through immunohistochemistry (IHC) and scoring methods. If a sample is identified as ALK-positive, the subject is likely to respond to treatment with an ALK inhibitor, such as crizotinib. Conversely, if the sample is ALK-negative, the subject is not likely to respond to this treatment.

Another significant patent focuses on image analysis for breast cancer prognosis. This method calculates heterogeneity for biomarkers in a tissue sample, which can be combined with an immunohistochemistry combination score to provide a prognosis for breast cancer recurrence. The process involves determining the percent positivity for various biomarkers and utilizing an imaging tool to support a digital pathologist's workflow.

Career Highlights

Crystal has worked with prominent organizations such as Ventana Medical Systems, Inc. and The Cleveland Clinic Foundation. Her experience in these institutions has allowed her to develop and refine her innovative approaches to cancer treatment.

Collaborations

Throughout her career, Crystal has collaborated with talented individuals, including Shalini Singh and Michael S. Barnes. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Crystal Schemp's work in cancer treatment technologies exemplifies her dedication to improving patient outcomes through innovation. Her patents and collaborations highlight her significant contributions to the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…